Forian (Forian) Interest Expense : $-0.83 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Forian Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Forian's interest expense for the three months ended in Mar. 2024 was $ -0.20 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.83 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Forian's Operating Income for the three months ended in Mar. 2024 was $ -1.77 Mil. Forian's Interest Expense for the three months ended in Mar. 2024 was $ -0.20 Mil. Forian did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Forian Interest Expense Historical Data

The historical data trend for Forian's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Forian Interest Expense Chart

Forian Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

-0.32

-0.85

-0.84

Forian Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial												-0.21	-0.21	-0.21	-0.20	-0.20

Forian Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.83 Mil.

Forian (NAS:FORA) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Forian's Interest Expense for the three months ended in Mar. 2024 was $-0.20 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-1.77 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $23.98 Mil.

Forian's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Forian did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Forian (Forian) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Forian Inc (NAS:FORA) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

41 University Drive, Suite 400, Newtown, PA, USA, 18940

Website

https://www.forian.com

Forian Inc provides a suite of SaaS solutions, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments, as well as cannabis dispensaries, manufacturers, cultivators, and regulators.

Executives

Martin J Wygod	director	P.O. BOX 676306, RANCHO SANTA FE CA 92067
Trotman Stanley S Jr	director
Max C Wygod	director, officer: Executive Chairman	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Max Wygod Family Dynasty Trust	10 percent owner	41 UNIVERSITY DRIVE, SUITE 400, NEWTOWN PA 18940
Michael Vesey	officer: Chief Financial Officer	4041-T HADLEY ROAD, S. PLAINFIELD NJ 07080
Jennifer Hajj	director	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Kristiina Md Vuori	director	C/O WEBMD HEALTH CORP., 111 EIGHTH AVENUE, NEW YORK NY 10011
Scott Matthew Ogur	director	C/O HELIX TCS, INC., 10200 E. GIRARD AVENUE, SUITE B420, DENVER CO 80231
Farren Clifford A Jr	officer: Chief Financial Officer	C/O SYNAVANT INC, 3445 PEACHTREE ROAD NE SUITE 1400, ATLANTA GA 30326
Adler Mark J Md	director
Ian Banwell	director	P.O. BOX 34004, CHARLOTTE NC 28234
Shahir Kassam-adams	director	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Adam H Dublin	director, officer: Chief Strategy Officer	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Daniel J Barton	director, officer: Chief Executive Officer	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Alyssa F Varadhan	director	41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940